Literature DB >> 31402279

Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index.

Cosimo De Nunzio1, Antonio Cicione2, Laura Izquierdo3, Riccardo Lombardo2, Giorgia Tema2, Giuseppe Lotrecchiano4, Andrea Minervini5, Giuseppe Simone6, Luca Cindolo7, Carlo D'Orta7, Tarek Ajami3, Alessandro Antonelli8, Marco Dellabella9, Antonio Alcaraz3, Andrea Tubaro2.   

Abstract

BACKGROUND: The purpose of this study was to assess patient frailty as a risk factor for radical cystectomy (RC) complications.
MATERIALS AND METHODS: We performed an analysis of prospectively collected data of consecutive patients 80 years of age or older who underwent RC and ureterocutaneostomy in 6 primary care European urology centers. Frailty was measured using a simplified frailty index (sFI) with a 5-item score including: (1) diabetes mellitus; (2) functional status; (3) chronic obstructive pulmonary disease; (4) congestive cardiac failure; and (5) hypertension, with a maximum 5-item score meaning high level of frailty. Within 90 days surgical complications were scored according to the Clavien Classification System (CCS). sFI ≥3 was considered as poor frailty status. Clinical and pathological variables were analyzed as predictors of severe complications (CCS ≥3).
RESULTS: One hundred seventeen patients were enrolled. Most patients reported an sFI score of 2 and 3, respectively, 31/117 (26.5%) and 45/117 patients (38.5%). CCS ≥3 occurred in 17/117 patients (14.5%). Patients with sFI ≥3 were significantly older than patients with sFI <3 (median age, 85 years [interquartile range (IQR), 82-86] versus 82 years [IQR, 80-84]; P = .001). Most CCS ≥3 scores occurred in patients with sFI ≥3: 13 (11.1%) versus 4 (3.4%; P = .02). No significative differences were detected in terms of length of hospital stay, pathological stage, and postoperative bowel canalization when related to sFI. sFI ≥3 was an independent risk factor of CCS ≥3 in univariate and multivariate analysis (respectively, odds ratio [OR], 3.81 [95% confidence interval (CI), 1.16-12.5; P = .02] and OR, 3.1 [95% CI, 0.7-13.7; P = .01]). Body mass index, age, American Society of Anesthesiologists score ≥3, and pathological stage were not related to CCS ≥3.
CONCLUSION: RC appears feasible in elderly patients with an sFI <3. In cases of sFI ≥3, this choice should be carefully valued, discussed, and possibly avoided because of a higher risk of complications.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Elderly; Fraily; Radical cystectomy; Ureterocutaneostomy

Mesh:

Year:  2019        PMID: 31402279     DOI: 10.1016/j.clgc.2019.07.002

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  12 in total

1.  The Association of Frailty with Outcomes after Cancer Surgery: A Systematic Review and Metaanalysis.

Authors:  Julia F Shaw; Dan Budiansky; Fayza Sharif; Daniel I McIsaac
Journal:  Ann Surg Oncol       Date:  2022-01-24       Impact factor: 5.344

2.  Early or Delayed Radical Cystectomy for High-risk Non-muscle-invasive Bladder Cancer: A Hard Dilemma to Solve.

Authors:  Cosimo De Nunzio; Riccardo Lombardo; Antonio Cicione
Journal:  Eur Urol Open Sci       Date:  2022-06-16

3.  Delayed ileal neobladder fistula caused by bladder stones: a case report.

Authors:  Dongming Lu; Yongyang Wu; Shangfan Liao; Xueping Xie; Dingjun Zhu; Shuchao Ye
Journal:  BMC Urol       Date:  2022-06-17       Impact factor: 2.090

4.  Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients.

Authors:  Radosław Piliszek; Anna A Brożyna; Witold R Rudnicki
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 5.  Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives.

Authors:  Liang G Qu; Nathan Lawrentschuk
Journal:  Res Rep Urol       Date:  2019-12-11

Review 6.  Frailty impact on postoperative complications and early mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review.

Authors:  Paola I Ornaghi; Luca Afferi; Alessandro Antonelli; Maria A Cerruto; Livio Mordasini; Agostino Mattei; Philipp Baumeister; Giancarlo Marra; Wojciech Krajewski; Andrea Mari; Francesco Soria; Benjamin Pradere; Evanguelos Xylinas; Alessandro Tafuri; Marco Moschini
Journal:  Arab J Urol       Date:  2020-11-02

7.  Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.

Authors:  Andrea Mari; Gianluca Muto; Fabrizio Di Maida; Riccardo Tellini; Riccardo Bossa; Claudio Bisegna; Riccardo Campi; Andrea Cocci; Lorenzo Viola; Antonio Grosso; Sabino Scelzi; Alberto Lapini; Marco Carini; Andrea Minervini
Journal:  Arab J Urol       Date:  2020-08-26

Review 8.  Neobladder "Function": Tips and Tricks for Surgery and Postoperative Management.

Authors:  Daniela Fasanella; Michele Marchioni; Luigi Domanico; Claudia Franzini; Antonino Inferrera; Luigi Schips; Francesco Greco
Journal:  Life (Basel)       Date:  2022-08-04

Review 9.  Immunogenic Cell Death Role in Urothelial Cancer Therapy.

Authors:  Reza Yadollahvandmiandoab; Mehrsa Jalalizadeh; Keini Buosi; Herney Andrés Garcia-Perdomo; Leonardo Oliveira Reis
Journal:  Curr Oncol       Date:  2022-09-18       Impact factor: 3.109

10.  Benchmarking PASADENA Consensus along the Learning Curve of Robotic Radical Cystectomy with Intracorporeal Neobladder: CUSUM Based Assessment.

Authors:  Riccardo Lombardo; Riccardo Mastroianni; Gabriele Tuderti; Mariaconsiglia Ferriero; Aldo Brassetti; Umberto Anceschi; Salvatore Guaglianone; Cosimo De Nunzio; Antonio Cicione; Andrea Tubaro; Michele Gallucci; Giuseppe Simone
Journal:  J Clin Med       Date:  2021-12-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.